Amylyx Pharmaceuticals (AMLX) Prepaid Assets (2021 - 2026)

Amylyx Pharmaceuticals (AMLX) recorded quarterly Prepaid Assets of $5.3 million in Q1 2026, down 21.46% quarter-over-quarter from $6.7 million in Q4 2025, and down 55.37% on a YoY basis from $11.8 million in Q1 2025.

Amylyx Pharmaceuticals (AMLX) Prepaid Assets (2021 - 2026) Analysis & Trends

Amylyx Pharmaceuticals' Prepaid Assets history runs 6 years deep, the most recent figure standing at $5.3 million for Q1 2026.

  • In Q1 2026, Prepaid Assets fell 55.37% year-over-year to $5.3 million; the TTM figure through Mar 2026 stood at $5.3 million (down 55.37% YoY), while the FY2025 annual figure was $6.7 million, down 46.4% from the prior year.
  • Prepaid Assets was $5.3 million for Q1 2026 at Amylyx Pharmaceuticals, down from $6.7 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $17.3 million in Q3 2023 to a low of $5.3 million in Q1 2026.
  • Historically, Prepaid Assets has averaged $10.9 million across 5 years, with a median of $10.3 million in 2022.
  • The sharpest annual moves came in 2023 and 2026: Prepaid Assets soared 107.99% in 2023, then tumbled 55.37% in 2026.
  • A 5-year view of Prepaid Assets shows it stood at $10.1 million in 2022, then soared by 47.64% to $14.9 million in 2023, then declined by 16.39% to $12.5 million in 2024, then tumbled by 46.4% to $6.7 million in 2025, then declined by 21.46% to $5.3 million in 2026.
  • The last three Prepaid Assets figures came in at $5.3 million (Q1 2026), $6.7 million (Q4 2025), and $9.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Amylyx Pharmaceuticals 1.51 Bn 1.51 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 5.26 Mn
Dec 31, 2025 6.69 Mn
Sep 30, 2025 9.26 Mn
Jun 30, 2025 5.96 Mn
Mar 31, 2025 11.78 Mn
Dec 31, 2024 12.48 Mn
Sep 30, 2024 9.14 Mn
Jun 30, 2024 12.82 Mn
Mar 31, 2024 16.89 Mn
Dec 31, 2023 14.93 Mn
Sep 30, 2023 17.34 Mn
Jun 30, 2023 11.79 Mn
Mar 31, 2023 12.75 Mn
Dec 31, 2022 10.11 Mn
Sep 30, 2022 8.34 Mn
Jun 30, 2022 9.46 Mn
Mar 31, 2022 10.28 Mn
Dec 31, 2021 5.39 Mn